bms-663068 and Long-QT-Syndrome

bms-663068 has been researched along with Long-QT-Syndrome* in 1 studies

Trials

1 trial(s) available for bms-663068 and Long-QT-Syndrome

Article	Year
Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure-Response Analysis. Clinical and translational science, 2020, Volume: 13, Issue:4 Topics: Adolescent; Adult; Anti-HIV Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Electrocardiography; Female; HIV Infections; HIV-1; Humans; Long QT Syndrome; Male; Middle Aged; Organophosphates; Piperazines; Prodrugs; Young Adult	2020

Article

Year

Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure-Response Analysis.

Clinical and translational science, 2020, Volume: 13, Issue:4

Topics: Adolescent; Adult; Anti-HIV Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Electrocardiography; Female; HIV Infections; HIV-1; Humans; Long QT Syndrome; Male; Middle Aged; Organophosphates; Piperazines; Prodrugs; Young Adult

2020